![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Tris Pharma Announces Acceptance of Its First Two NDAs
Tris Pharma Announces Acceptance of Its First Two NDAs
May 13, 2009
Tris Pharma, a privately owned specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration has accepted its first two New Drug Applications (NDAs) for once-daily formulations of a cardiovascular drug.
Sys-Con Media
Sys-Con Media
Upcoming Events
-
21Oct